Keywords: ADVENTRX, SythRx, CytRx, Rheologic and antithrombotic gents, Poloxamer 188

ADVENTRX inks deal to acquire SynthRx in milestone-dependent all stock transaction

Article | 15 February 2011

San Diego, USA-based ADVENTRX Pharmaceuticals (NYSE Amex: ANX) has entered into a definitive agreement to acquire privately-held biotech firm SynthRx, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

SynthRx

CytRx

ADVENTRX Pharma

Go to company listing